| Open Document File Size: 4,62 MBShare Result on Facebook
City Chesterbrook / Reference / / Company Auxilium Pharmaceuticals Inc. / / Event FDA Phase / / IndustryTerm educational tool / TREATMENT OF PEYRONIE’S DISEASE / communication plan / certified healthcare setting / healthcare / healthcare setting certification / certified healthcare providers / healthcare provider prescribing / Treatment for Peyronie’s Disease / healthcare settings / healthcare providers / healthcare setting / / MedicalCondition XIAFLEX-associated pruritus / tendonitis / anaphylaxis / severe hypersensitivity / serious injury / contracture / hypersensitivity / ligament injury / pruritus / Other Serious Injury / mild allergic reactions / severe allergic reactions / Dupuytren’s contracture / joint contracture / serious hypersensitivity / OF PEYRONIE’S DISEASE / serious penile injuries / Peyronie’s disease / permanent injury / complex regional pain syndrome / serious injuries / penile injuries / / Organization Administration of XIAFLEX for Dupuytren / FDA / / / Position Counsel / MP / Representative / Corporal / / Product XIAFLEX injections / XIAFLEX® / XIAFLEX / Peyronie / / ProvinceOrState Pennsylvania / / PublishedMedium The Mediation Guide / the Training Guide / / URL www.XIAFLEXREMS.com / www.fda.gov/medwatch/report.htm / /
SocialTag |
Xiaflex (collagenase clostridium histolyticum) Drug Class: Bacterial collagenase enzyme